Headache, an increased incidence of respiratory-tract infection, and gastrointestinal disturbances have been reported with montelukast and other leukotriene antagonists. Other adverse effects have included generalised pain, arthralgia, myalgia, fever and dizziness. Elevations in liver enzyme values have occurred, and rarely, symptomatic hepatitis or hyperbilirubinemia.